Ameya Sadguru Kulkarni
Molecular Biology · 2020
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 27 citations into it
- Endocrinology, Diabetes and Metabolism — 5 citations into it
Whom Ameya Sadguru Kulkarni trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Ameya Sadguru Kulkarni overall
Papers from Ameya Sadguru Kulkarni's perspective
Ordered by how strongly the researchers Ameya Sadguru Kulkarni trusts endorse each paper. Same corpus, a different order for every researcher.
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase (Nature)
- Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. (Biochemical Journal)
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (Nature)
- Metformin and the gastrointestinal tract (Diabetologia)
- The hallmarks of aging. (Cell)
- Metformin as a Tool to Target Aging (Cell Metabolism)
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status (Circulation Research)
- Proteostasis and aging (Nature Medicine)
- The proteostasis network and its decline in ageing (Nature reviews. Molecular cell biology)
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin (Nature Medicine)
Their papers
- Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) — 641 citations